CKD-379

DRUG3 trials

Sponsors

Chong Kun Dang Pharmaceutical

Conditions

Type II Diabetes Mellitus

Phase 1

Pharmacokinetics and Safety/Tolerability of CKD-379

CompletedNCT05719155

Chong Kun Dang PharmaceuticalType II Diabetes Mellitus

Start: 2023-02-27End: 2023-04-10Updated: 2023-05-11

Study to Evaluate the Safety and Pharmacokinetics of CKD-379

Chong Kun Dang PharmaceuticalType II Diabetes Mellitus

Start: 2023-06-02End: 2023-10-30Updated: 2023-07-19

A Clinical Trial to Evaluate the Food Effect of CKD-379

CompletedNCT06652971

Chong Kun Dang PharmaceuticalType II Diabetes Mellitus

Start: 2024-11-05End: 2024-12-17Updated: 2024-12-30